Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 4, 2023.
A new study out of the U.K. backed Dexcom’s real-time continuous glucose monitoring. The news comes shortly after the company had big wins in the U.S Fast Five hosts Danielle Kirsh and Sean Whooley give an inside look at what the study detailed and what this could mean for people with diabetes in the U.K.
Enovis is continuing to expand its foot and ankle portfolio – this time with a strategic product acquisition. Whooley details the acquisition and how Enovis is supplementing its growing portfolio.
Earnings season in the medical device industry continues. This week, LivaNova reported first-quarter earnings that showed it more than doubled its profits compared to Q1 2022. Kirsh and Whooley discuss the financial details and which LivaNova segments outperform others.
Magenta Medical’s recent $55 million funding round will enable the company to accelerate the development and commercialization of its miniature heart pump technology. The successful funding round is a sign of investor confidence in the company’s innovative miniature heart pump technology. The Fast Five hosts give all the details of the device.
DarioHealth’s pricing of its recent offering is part of the company’s efforts to raise capital to fund its continued growth and expansion. Whooley provides more information about DarioHealth’s cash balance and other financial milestones it achieved.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
